Discovery and structure - activity relationship studies of indole derivatives as liver X receptor (LXR) agonists

被引:8
作者
Bakir, Farid
Kher, Sunil
Pannala, Madhavi
Wilson, Norma
Nguyen, Trang
Sircar, Ila
Takedomi, Kel
Fukushima, Chiaki
Zapf, James
Xu, Kui
Zhang, Shao-Hui
Liu, Juping
Morera, Lisa
Schneider, Lisa
Sakurai, Naoki
Jack, Rick
Cheng, Jie-Fei
机构
[1] Tanabe Res Labs USA Inc, Dept Chem, San Diego, CA 92121 USA
[2] Tanabe Res Labs USA Inc, Dept Computat Discovery, San Diego, CA 92121 USA
[3] Tanabe Res Labs USA Inc, Dept Biol, San Diego, CA 92121 USA
[4] Tanabe Seiyaku Co Ltd, Dept Chem, Toda, Saitama, Japan
关键词
virtual screening; high-throughput gene profiling; LXR agonist; liver X receptor;
D O I
10.1016/j.bmcl.2007.03.076
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A structurally novel liver X receptor (LXR) agonist (1) was identified from internal compound collection utilizing the combination of structure-based virtual screening and high-throughput gene profiling. Compound 1 increased ABCA1 gene expression by eightfold and SREBP1c by threefold in differentiated THP-1 macrophage cell lines. Confirmation of its agonistic activity against LXR was obtained in the co-factor recruitment and reporter transactivation assays. Structure-activity relationship studies on compound 1 are described. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3473 / 3479
页数:7
相关论文
共 22 条
[1]  
Attie AD, 2001, J LIPID RES, V42, P1717
[2]   Liver X receptor agonists as a treatment for atherosclerosis [J].
Bennett, DJ ;
Cooke, AJ ;
Edwards, AS ;
Moir, E ;
Ray, PC .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) :967-982
[3]   Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis [J].
Cao, GQ ;
Liang, Y ;
Broderick, CL ;
Oldham, BA ;
Beyer, TP ;
Schmidt, RJ ;
Zhang, YY ;
Stayrook, KR ;
Suen, C ;
Otto, KA ;
Miller, AR ;
Dai, JN ;
Foxworthy, P ;
Gao, H ;
Ryan, TP ;
Jiang, XC ;
Burris, TP ;
Eacho, PI ;
Etgen, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :1131-1136
[4]   Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines [J].
Collins, JL ;
Fivush, AM ;
Watson, MA ;
Galardi, CM ;
Lewis, MC ;
Moore, LB ;
Parks, DJ ;
Wilson, JG ;
Tippin, TK ;
Binz, JG ;
Plunket, KD ;
Morgan, DG ;
Beaudet, EJ ;
Whitney, KD ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) :1963-1966
[5]   Pd-catalyzed tandem C-N/C-C coupling of gem-dihalovinyl systems: A modular synthesis of 2-substituted indoles [J].
Fang, YQ ;
Lautens, M .
ORGANIC LETTERS, 2005, 7 (16) :3549-3552
[6]   Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice [J].
Grefhorst, A ;
van Dijk, TH ;
Hammer, A ;
van der Sluijs, FH ;
Havinga, R ;
Havekes, LM ;
Romijn, JA ;
Groot, PH ;
Reijngoud, DJ ;
Kuipers, F .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 289 (05) :E829-E838
[7]   Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ [J].
Janowski, BA ;
Grogan, MJ ;
Jones, SA ;
Wisely, GB ;
Kliewer, SA ;
Corey, EJ ;
Mangelsdorf, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :266-271
[8]   Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure [J].
Jaye, MC ;
Krawiec, JA ;
Campobasso, N ;
Smallwood, A ;
Qiu, CY ;
Lu, Q ;
Kerrigan, JJ ;
Alvaro, MDL ;
Laffitte, B ;
Liu, WS ;
Marino, JP ;
Meyer, CR ;
Nichols, JA ;
Parks, DJ ;
Perez, P ;
Sarov-Blat, L ;
Seepersaud, SD ;
Steplewski, KM ;
Thompson, SK ;
Wang, P ;
Watson, MA ;
Webb, CL ;
Haigh, D ;
Caravella, JA ;
Macphee, CH ;
Willson, TM ;
Collins, JL .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (17) :5419-5422
[9]  
Leuckart R., 1885, BER DTSCH CHEM GES, V18, P2341, DOI DOI 10.1016/J.CEJ.2015.03.094
[10]   Discovery and optimization of a novel series of liver X receptor-α agonists [J].
Li, LP ;
Liu, JW ;
Zhu, LS ;
Cutler, S ;
Hasegawa, H ;
Shan, B ;
Medina, JC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (06) :1638-1642